| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |